# Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

> **NCT02507336** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 2 (actual)

## Conditions studied

- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT02507336
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-24
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507336, "Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02507336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*